AP3499A - Pyrazolospiroketone derivatives for use as acetyl-coa carboxylase inhibitors - Google Patents

Pyrazolospiroketone derivatives for use as acetyl-coa carboxylase inhibitors

Info

Publication number
AP3499A
AP3499A AP2013007129A AP2013007129A AP3499A AP 3499 A AP3499 A AP 3499A AP 2013007129 A AP2013007129 A AP 2013007129A AP 2013007129 A AP2013007129 A AP 2013007129A AP 3499 A AP3499 A AP 3499A
Authority
AP
ARIPO
Prior art keywords
pyrazolospiroketone
acetyl
derivatives
coa carboxylase
carboxylase inhibitors
Prior art date
Application number
AP2013007129A
Other languages
English (en)
Other versions
AP2013007129A0 (en
Inventor
James Alfred Southers Jr
Robert Lee Dow
David Andrew Griffith
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of AP2013007129A0 publication Critical patent/AP2013007129A0/xx
Application granted granted Critical
Publication of AP3499A publication Critical patent/AP3499A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Photographic Processing Devices Using Wet Methods (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
AP2013007129A 2011-04-22 2012-04-09 Pyrazolospiroketone derivatives for use as acetyl-coa carboxylase inhibitors AP3499A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161478240P 2011-04-22 2011-04-22
PCT/IB2012/051732 WO2012143813A1 (en) 2011-04-22 2012-04-09 Pyrazolospiroketone derivatives for use as acetyl - coa carboxylase inhibitors

Publications (2)

Publication Number Publication Date
AP2013007129A0 AP2013007129A0 (en) 2013-09-30
AP3499A true AP3499A (en) 2015-12-31

Family

ID=46025823

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2013007129A AP3499A (en) 2011-04-22 2012-04-09 Pyrazolospiroketone derivatives for use as acetyl-coa carboxylase inhibitors

Country Status (41)

Country Link
US (4) US8802688B2 (sl)
EP (1) EP2699576B1 (sl)
JP (1) JP5657174B2 (sl)
KR (1) KR101567659B1 (sl)
CN (2) CN103492388A (sl)
AP (1) AP3499A (sl)
AR (1) AR086198A1 (sl)
AU (1) AU2012245996B2 (sl)
CA (1) CA2831380C (sl)
CL (1) CL2013002794A1 (sl)
CO (1) CO6801757A2 (sl)
CR (1) CR20130464A (sl)
CU (1) CU24164B1 (sl)
CY (1) CY1117122T1 (sl)
DK (1) DK2699576T3 (sl)
DO (1) DOP2013000243A (sl)
EA (1) EA022375B1 (sl)
EC (1) ECSP13013038A (sl)
ES (1) ES2561452T3 (sl)
GE (1) GEP20166474B (sl)
GT (1) GT201300258A (sl)
HR (1) HRP20151397T1 (sl)
HU (1) HUE028602T2 (sl)
IL (1) IL228949A (sl)
MA (1) MA35061B1 (sl)
ME (1) ME02312B (sl)
MX (1) MX348860B (sl)
MY (1) MY162167A (sl)
NI (1) NI201300111A (sl)
NZ (1) NZ616156A (sl)
PE (1) PE20141187A1 (sl)
PL (1) PL2699576T3 (sl)
PT (1) PT2699576E (sl)
RS (1) RS54526B1 (sl)
SG (1) SG194142A1 (sl)
SI (1) SI2699576T1 (sl)
TN (1) TN2013000393A1 (sl)
TW (1) TWI464171B (sl)
UA (1) UA107753C2 (sl)
UY (1) UY34027A (sl)
WO (1) WO2012143813A1 (sl)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GEP20146169B (en) * 2009-11-10 2014-09-25 Pfizer N1-pyrazolospiroketone acetyl-coa carboxylase inhibitors
CN102491974B (zh) * 2011-12-12 2013-08-07 南京药石药物研发有限公司 1-（2-氟苄基）-1H-吡唑并[3，4-b]吡啶-3-甲脒盐酸盐的合成方法
US9447026B2 (en) 2013-03-14 2016-09-20 Kalyra Pharmaceuticals, Inc. Bicyclic analgesic compounds
CA2911932A1 (en) 2013-05-10 2014-11-13 Nimbus Apollo, Inc. Acc inhibitors and uses thereof
EP2994141A4 (en) 2013-05-10 2016-11-23 Nimbus Apollo Inc ACC-HEMMER AND USES THEREOF
EA201591959A1 (ru) 2013-05-10 2016-03-31 Нимбус Аполло, Инк. Ингибиторы акк и их применение
WO2015036892A1 (en) * 2013-09-12 2015-03-19 Pfizer Inc. Use of acetyl-coa carboxylase inhibitors for treating acne vulgaris
EP3670496A3 (en) 2013-10-17 2020-09-30 Shionogi&Co., Ltd. Acc2 inhibitors
CN105814013A (zh) * 2013-12-12 2016-07-27 卡利拉制药公司 双环烷基化合物及合成
WO2015134710A1 (en) 2014-03-07 2015-09-11 Kalyra Pharmaceuticals, Inc. Propellane derivates and synthesis
US10457502B2 (en) 2014-05-22 2019-10-29 Symbotic Canada Ulc Tool and method for layer depalletizing
CA2961605C (en) 2014-09-17 2023-01-10 Kalyra Pharmaceuticals, Inc. Bicyclic compounds
EP3398604A4 (en) * 2015-12-31 2019-06-19 Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. TRACETYL-3-HYDROXYPHENYLADENOSINE AND APPLICATION IN THE PREPARATION OF A PHARMACEUTICAL MEDICAMENT FOR PREVENTING OR TREATING NON-ALCOHOLIC FATERS
CN106580986B (zh) * 2016-11-28 2017-09-15 王保亮 一种治疗少弱精子症的药物组合物
CN111094259B (zh) 2017-05-15 2023-08-11 里科瑞尔姆Ip控股有限责任公司 止痛化合物
HUE061885T2 (hu) * 2017-11-21 2023-08-28 Pfizer 4-(4-(4-(1-Izopropil-7-oxo-1,4,6,6,7-tetrahidrospiro[indazol-5,4'-piperidin] -1'-karbonil)-6-metoxipiridin-2-il)-benzoesav kristályos 2-amino-2-(hidroximetil)-propán-1,3-diol sója
CN111574530B (zh) * 2020-04-21 2022-07-26 徐州医科大学 一种acc抑制剂及其医药用途
CN118271307A (zh) * 2022-12-30 2024-07-02 苏州浦合医药科技有限公司 Prmt5-mta抑制剂

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012042433A1 (en) * 2010-09-30 2012-04-05 Pfizer Inc. N1-PYRAZOLOSPIROKETONE ACETYL-CoA CARBOXYLASE INHIBITORS

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0901786T3 (da) 1997-08-11 2007-10-08 Pfizer Prod Inc Faste farmaceutiske dispersioner med foröget biotilgængelighed
RS63203A (en) 2001-02-28 2006-12-15 Merck & Co.Inc. Acylated piperidine derivatives as melanocortin-4 receptor agonists
IL163659A0 (en) 2002-02-27 2005-12-18 Pfizer Prod Inc Acc inhibitors
US7105526B2 (en) 2002-06-28 2006-09-12 Banyu Pharmaceuticals Co., Ltd. Benzimidazole derivatives
WO2004092179A1 (ja) 2003-04-14 2004-10-28 Nippon Soda Co. Ltd. スピロ誘導体、製造法および抗酸化薬
JP2005119987A (ja) 2003-10-15 2005-05-12 Ajinomoto Co Inc アシルスルホンアミド誘導体
ATE437870T1 (de) 2004-05-12 2009-08-15 Pfizer Prod Inc Prolinderivate und deren verwendung als dipeptidylpeptidase-iv-inhibitoren
US20050267221A1 (en) 2004-05-14 2005-12-01 Research Development Foundation Use of curcumin and analogues thereof as inhibitors of ACC2
AU2005247693A1 (en) 2004-05-25 2005-12-08 Pfizer Products Inc. Tetraazabenzo[E]azulene derivatives and analogs thereof
PA8660701A1 (es) 2005-02-04 2006-09-22 Pfizer Prod Inc Agonistas de pyy y sus usos
BRPI0613427A2 (pt) 2005-07-19 2012-10-30 Merck & Co Inc composto ou seu sal ou éster, composição farmacêutica, agente terapêutico, e , uso do composto ou seu sal ou éster
CA2617042A1 (en) 2005-07-29 2007-02-01 Takeda Pharmaceutical Company Limited Spiro-cyclic compound
DE602006019304D1 (de) 2005-11-18 2011-02-10 Merck Sharp & Dohme Spirohydantoin-aryl-cgrp-rezeptorantagonisten
CA2641766A1 (en) 2006-02-15 2007-08-23 Abbott Laboratories Novel acetyl-coa carboxylase (acc) inhibitors and their use in diabetes, obesity and metabolic syndrome
WO2007122482A1 (en) 2006-04-20 2007-11-01 Pfizer Products Inc. Fused phenyl amido heterocyclic compounds for the prevention and treatment of glucokinase-mediated diseases
JP2010511035A (ja) 2006-11-29 2010-04-08 ファイザー・プロダクツ・インク スピロケトンアセチルＣｏＡカルボキシラーゼ阻害剤
PE20081559A1 (es) 2007-01-12 2008-11-20 Merck & Co Inc DERIVADOS DE ESPIROCROMANONA SUSTITUIDOS COMO INHIBIDORES DE ACETIL CoA CARBOXILASA
WO2008102749A1 (ja) * 2007-02-20 2008-08-28 Takeda Pharmaceutical Company Limited 複素環化合物
JP5404601B2 (ja) 2007-04-12 2014-02-05 ファイザー・インク 新規な３−アミド−ピロロ［３，４−ｃ］ピラゾール−５（１Ｈ，４Ｈ，６Ｈ）カルバルデヒド誘導体
US20090036425A1 (en) 2007-08-02 2009-02-05 Pfizer Inc Substituted bicyclolactam compounds
US7981904B2 (en) 2008-03-20 2011-07-19 Takeda Pharmaceutical Company Limited Acetyl CoA carboxylase inhibitors
CA2724603A1 (en) 2008-05-28 2009-12-03 Pfizer Inc. Pyrazolospiroketone acetyl-coa carboxylase inhibitors
ES2545231T3 (es) * 2008-05-28 2015-09-09 Pfizer Inc. Inhibidores de pirazoloespirocetona acetil-CoA carboxilasa
WO2010002010A1 (en) * 2008-07-04 2010-01-07 Banyu Pharmaceutical Co.,Ltd. Novel spirochromanone carboxylic acids
EP2310015A4 (en) 2008-07-14 2011-10-26 Cropsolution Inc ACETYL-COENZYME-CARBOXYLASE MODULATORS AND METHODS OF USE THEREOF
JP2011529483A (ja) 2008-07-29 2011-12-08 ファイザー・インク フッ素化ヘテロアリール
WO2010023594A1 (en) 2008-08-28 2010-03-04 Pfizer Inc. Dioxa-bicyclo[3.2.1.]octane-2,3,4-triol derivatives
WO2010086820A1 (en) 2009-02-02 2010-08-05 Pfizer Inc. 4-amino-5-oxo-7, 8-dihydropyrimido [5,4-f] [1,4] oxazepin-6 (5h) -yl) phenyl derivatives, pharmaceutical compositions and uses thereof
PL2406253T3 (pl) 2009-03-11 2013-10-31 Pfizer Pochodne benzofuranylu jako inhibitory glukokinazy
WO2010103438A1 (en) 2009-03-11 2010-09-16 Pfizer Inc. Substituted indazole amides and their use as glucokinase activators
CA2754523A1 (en) 2009-03-20 2010-09-23 Pfizer Inc. 3-oxa-7-azabicyclo[3.3.1]nonanes
JP2012526097A (ja) 2009-05-08 2012-10-25 ファイザー・インク Ｇｐｒ１１９調節因子
JP2012526096A (ja) 2009-05-08 2012-10-25 ファイザー・インク Ｇｐｒ１１９調節因子
SG175995A1 (en) 2009-06-05 2011-12-29 Pfizer L- ( piperidin-4-yl) -pyrazole derivatives as gpr 119 modulators
WO2011005611A1 (en) 2009-07-09 2011-01-13 Merck Sharp & Dohme Corp. Neuromedin u receptor agonists and uses thereof
GEP20146169B (en) * 2009-11-10 2014-09-25 Pfizer N1-pyrazolospiroketone acetyl-coa carboxylase inhibitors
WO2011058473A1 (en) * 2009-11-10 2011-05-19 Pfizer Inc. N2-pyrazolospiroketone acetyl-coa carboxylase inhibitors

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012042433A1 (en) * 2010-09-30 2012-04-05 Pfizer Inc. N1-PYRAZOLOSPIROKETONE ACETYL-CoA CARBOXYLASE INHIBITORS

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
SCOTT W. BAGLEY ET AL.: "Synthesis of 7-Oxo-dihydrospiro[indazole-5,4'-piperidine] Acetyl-CoA Carboxylase Inhibitors", THE JOURNAL OF ORGANIC CHEMISTRY, vol. 77, no. 3, 3 February 2012 (2012-02-03), pages 1497-1506, XP55030451 *

Also Published As

Publication number Publication date
CN106117205A (zh) 2016-11-16
CL2013002794A1 (es) 2013-12-27
CA2831380A1 (en) 2012-10-26
SG194142A1 (en) 2013-11-29
MX348860B (es) 2017-06-30
UY34027A (es) 2013-04-05
CN103492388A (zh) 2014-01-01
MY162167A (en) 2017-05-31
CN106117205B (zh) 2018-09-21
DOP2013000243A (es) 2013-12-31
AU2012245996A1 (en) 2013-10-03
CR20130464A (es) 2013-10-16
AR086198A1 (es) 2013-11-27
CA2831380C (en) 2016-04-05
US8802688B2 (en) 2014-08-12
AU2012245996B2 (en) 2016-09-01
ECSP13013038A (es) 2014-01-31
EA022375B1 (ru) 2015-12-30
NZ616156A (en) 2014-08-29
TWI464171B (zh) 2014-12-11
WO2012143813A1 (en) 2012-10-26
UA107753C2 (xx) 2015-02-10
EP2699576A1 (en) 2014-02-26
TN2013000393A1 (fr) 2015-01-20
EP2699576B1 (en) 2015-12-09
RS54526B1 (en) 2016-06-30
HRP20151397T1 (hr) 2016-01-15
MX2013012313A (es) 2014-01-31
SI2699576T1 (sl) 2016-02-29
CU24164B1 (es) 2016-03-31
NI201300111A (es) 2014-02-12
US20140323730A1 (en) 2014-10-30
US20150336958A1 (en) 2015-11-26
CY1117122T1 (el) 2017-04-05
JP5657174B2 (ja) 2015-01-21
MA35061B1 (fr) 2014-04-03
CU20130126A7 (es) 2014-01-29
KR20140015511A (ko) 2014-02-06
TW201305162A (zh) 2013-02-01
DK2699576T3 (en) 2016-02-15
PT2699576E (pt) 2016-03-09
GEP20166474B (en) 2016-05-10
CO6801757A2 (es) 2013-11-29
IL228949A (en) 2016-11-30
US20120270893A1 (en) 2012-10-25
PE20141187A1 (es) 2014-09-18
PL2699576T3 (pl) 2016-05-31
HUE028602T2 (hu) 2016-12-28
JP2014515755A (ja) 2014-07-03
GT201300258A (es) 2015-06-02
KR101567659B1 (ko) 2015-11-09
AP2013007129A0 (en) 2013-09-30
ME02312B (me) 2016-06-20
US20150112068A1 (en) 2015-04-23
ES2561452T3 (es) 2016-02-26
IL228949A0 (en) 2013-12-31
EA201391288A1 (ru) 2014-04-30

Similar Documents

Publication Publication Date Title
IL284539A (en) Heterocycloamines as PI3K inhibitors
AP3499A (en) Pyrazolospiroketone derivatives for use as acetyl-coa carboxylase inhibitors
HK1209733A1 (en) N1/n2-lactam acetyl-coa carboxylase inhibitors n1/n2- a
HK1195552A1 (en) Pyrrolotriazinone derivatives as pi3k inhibitors pi3k
SI2621493T1 (sl) Zaviralci N1-pirazolospiroketon acetil-CoA-karboksilaze
ZA201305826B (en) Substituted amminobutyric derivatives as neprilysin inhibitors
IL228103A0 (en) Amino-quinolines as kinase inhibitors
EP2685992A4 (en) AMINO-QUINOLINES AS KINASE INHIBITORS